Vigonvita Life Sciences Co., Ltd. issued new Terms of Reference outlining the responsibilities and procedures for its Nomination Committee under the Board of Directors. The committee is formed to optimize the selection and appointment of directors and senior management, thereby strengthening corporate governance.

According to the announcement, the Nomination Committee will consist of at least three directors, with a majority being independent non-executive directors. Its responsibilities include reviewing and recommending suitable board candidates, devising selection criteria, assessing the independence of proposed independent non-executive directors, and advising on the re-appointment of existing directors.

The updated guidelines specify that the committee is accountable to the Board, and its recommendations are subject to the Board’s official review and decision. The Terms of Reference also clarify detailed procedures on candidate sourcing, qualifications, and documentation steps before finalizing any nomination. Finally, comprehensive meeting rules, quorum requirements, and written resolution procedures are defined to ensure the committee’s decisions are transparent and consistent with relevant regulatory requirements.